Journal of Biological Chemistry · 2005 · 34 citations · 26 references
Life SciencesBiologyMicrobiologyMicrobial PathogenesisMycologySignal TransductionFungal BiochemistryFungal Cell BiologyFungal GeneticsFungal MetabolismFungal PathogenesisGene Regulation In MicrobesDiacylglycerol MetabolismFungal Gene ExpressionFungal Gene RegulationFungal Pathogenicity FactorsFungal Signal TransductionFungal Transcriptional RegulationLuciferase Reporter AssaysSphingolipid Biosynthesis
Inositol-phosphorylceramide synthase 1 (Ipc1) is a fungal-specific enzyme that regulates the level of two bioactive molecules, phytoceramide and diacylglycerol (DAG). In previous studies, we demonstrated that Ipc1 regulates the expression of the antiphagocytic protein 1 (App1), a novel fungal factor involved in pathogenicity of Cryptococcus neoformans. Here, we investigated the molecular mechanism by which Ipc1 regulates App1. To this end, the APP1 promoter was fused to the firefly luciferase gene in the C. neofor-mans GAL7:IPC1 strain, in which the Ipc1 expression can be modulated, and found that the luciferase activity was indeed regulated when Ipc1 was modulated. Next, using the luciferase reporter assay in both C. neoformans wild-type and GAL7:IPC1 strains, we investigated the role of DAG and sphingolipids in the activation of the APP1 promoter and found that treatment with 1,2-dioctanoylglycerol does increase APP1 transcription, whereas treatment with phytosphingosine or ceramides does not. Two putative consensus sequences were found in the APP1 promoter for ATF and AP-2 transcription factors. Mutagenesis analysis of these sequences revealed that they play a key role in the regulation of APP1 transcription: ATF is an activator, whereas AP-2 in a negative regulator. Finally, we identified a putative Atf2 transcription factor, which is required for APP1 transcription and under the control of Ipc1-DAG pathway. These studies provide novel regulatory mechanisms of the sphingolipid pathway involved in the regulation of gene transcription of C. neoformans. Inositol-phosphorylceramide synthase 1 (Ipc1) is a fungal-specific enzyme that regulates the level of two bioactive molecules, phytoceramide and diacylglycerol (DAG). In previous studies, we demonstrated that Ipc1 regulates the expression of the antiphagocytic protein 1 (App1), a novel fungal factor involved in pathogenicity of Cryptococcus neoformans. Here, we investigated the molecular mechanism by which Ipc1 regulates App1. To this end, the APP1 promoter was fused to the firefly luciferase gene in the C. neofor-mans GAL7:IPC1 strain, in which the Ipc1 expression can be modulated, and found that the luciferase activity was indeed regulated when Ipc1 was modulated. Next, using the luciferase reporter assay in both C. neoformans wild-type and GAL7:IPC1 strains, we investigated the role of DAG and sphingolipids in the activation of the APP1 promoter and found that treatment with 1,2-dioctanoylglycerol does increase APP1 transcription, whereas treatment with phytosphingosine or ceramides does not. Two putative consensus sequences were found in the APP1 promoter for ATF and AP-2 transcription factors. Mutagenesis analysis of these sequences revealed that they play a key role in the regulation of APP1 transcription: ATF is an activator, whereas AP-2 in a negative regulator. Finally, we identified a putative Atf2 transcription factor, which is required for APP1 transcription and under the control of Ipc1-DAG pathway. These studies provide novel regulatory mechanisms of the sphingolipid pathway involved in the regulation of gene transcription of C. neoformans. Inositol-phosphorylceramide synthase 1 (Ipc1) 3The abbreviations used are:Ipc1inositol-phosphorylceramide synthase 1DAGdiacylglycerolATFactivating transcription factorLUCluciferaseNAT1nourseothricin acetyltransferase 1HYGhygromycin BACTactinUTRuntranslated regionAPP1antiphagocytic protein 1SDWsterile-distilled waterPKAprotein kinase APKCprotein kinase C is a fungal-specific enzyme of the sphingolipid pathway (Fig. 1) that regulates the level of phytoceramide and diacylglycerol (DAG), two well established bioactive molecules in mammalian cells, which regulate key cellular functions such as cell growth and viability (1Dickson R.C. Lester R.L. Biochim. Biophys. Acta. 1999; 1438: 305-321Crossref PubMed Scopus (130) Google Scholar, 2Chung N. Obeid L.M. Methods Enzymol. 2000; 311: 319-331Crossref PubMed Scopus (11) Google Scholar, 3Luberto C. Hannun Y.A. Lipids. 1999; 34: S5-S11Crossref PubMed Google Scholar, 4Bell R. Burns D. Okazaki T. Hannun Y. Adv. Exp. Med. Biol. 1992; 318: 275-284Crossref PubMed Scopus (10) Google Scholar, 5Pinto W.J. Srinivasan B. Shepherd S. Schmidt A. Dickson R.C. Lester R.L. J. Bacteriol. 1992; 174: 2565-2574Crossref PubMed Google Scholar, 6Hannun Y.A. Luberto C. Argraves K.M. Biochemistry. 2001; 40: 4893-4903Crossref PubMed Scopus (442) Google Scholar). On the other hand, the role of these lipids in signaling in yeast cells is poorly understood. inositol-phosphorylceramide synthase 1 diacylglycerol activating transcription factor luciferase nourseothricin acetyltransferase 1 hygromycin B actin untranslated region antiphagocytic protein 1 sterile-distilled water protein kinase A protein kinase C Although the presence of sphingolipid enzymes has been demonstrated in Saccharomyces cerevisiae (7Heidler S.A. Radding J.A. Antimicrob. Agents Chemother. 1995; 39: 2765-2769Crossref PubMed Scopus (91) Google Scholar), and in pathogenic fungi, such as Aspergillus fumigatus (8Kuroda M. Hashida-Okado T. Yasumoto R. Gomi K. Kato I. Takesako K. Mol. Gen. Genet. 1999; 261: 290-296Crossref PubMed Scopus (46) Google Scholar), Candida albicans, and Cryptococcus neoformans (9Heidler S.A. Radding J.A. Biochim. Biophys. Acta. 2000; 1500: 147-152Crossref PubMed Scopus (54) Google Scholar), studies of sphingolipid-mediated signaling transduction in pathogenic fungi are in their infancy. Studies in S. cerevisiae showed that Ipc1 modulates the level of phytoceramide and DAG (10Cerbon J. Falcon A. Hernandez-Luna C. Segura-Cobos D. Biochem. J. 2005; 388: 169-176Crossref PubMed Scopus (26) Google Scholar) but whether these lipids regulate signaling in this microorganism has yet to be elucidated. Whereas in mammalian cells DAG is a well known activator of protein kinase C (PKC), DAG does not activate the fungal homolog Pkc1 in S. cerevisiae (11Watanabe M. Chen C.Y. Levin D.E. J. Biol. Chem. 1994; 269: 16829-16836Abstract Full Text PDF PubMed Google Scholar, 12Antonsson B. Montessuit S. Friedli L. Payton M.A. Paravicini G. J. Biol. Chem. 1994; 269: 16821-16828Abstract Full Text PDF PubMed Google Scholar) or in C. albicans (13Paravicini G. Mendoza A. Antonsson B. Cooper M. Losberger C. Payton M.A. Yeast. 1996; 12: 741-756Crossref PubMed Scopus (70) Google Scholar). Thus, if DAG regulates signaling in S. cerevisiae or C. albicans this regulation would be exerted through proteins other than Pkc1. On the other hand, C. neoformans Pkc1 contains a putative DAG-binding domain, or C1 domain, which is highly homologous to the C1 domain of DAG-dependent mammalian PKCs (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar). In recent studies, we showed that Ipc1 activates Pkc1 in C. neoformans through a DAG-dependent mechanism (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar). This activation is mediated by the C1 domain of Pkc1 and regulates the localization and function of laccase (15Heung L.J. Kaiser A.E. Luberto C. Del Poeta M. J. Biol. Chem. 2005; 280: 28547-28555Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar), an enzyme that catalyzes melanin, which is required for the pathogenicity of C. neoformans. Additional studies revealed that Ipc1 also plays a role in the regulation of phagocytosis of C. neoformans, through the modulation of a novel fungal factor called antiphagocytic protein 1 (App1), which inhibits the attachment and ingestion of fungal cells by macrophages (16Luberto C. Martinez-Marino B. Taraskiewicz D. Bolanos B. Chitano P. Toffaletti D.L. Cox G.M. Perfect J.R. Hannun Y.A. Balish E. Del Poeta M. J. Clin. Investig. 2003; 112: 1080-1094Crossref PubMed Scopus (115) Google Scholar). Ipc1 controls App1 at the mRNA level, suggesting a transcriptional or post-transcriptional activation. Therefore, we sought to examine the possibility that Ipc1 and the lipids that it modulates, such as phytoceramide or/and DAG, may regulate the transcriptional activation of fungal factor(s), such as App1. To study the mechanism of the transcriptional regulation of the APP1 gene by Ipc1, the APP1 promoter was fused to the firefly luciferase gene in both C. neoformans wild-type and the GAL7:IPC1 strain, in which Ipc1 can be regulated by growing yeast cells in glucose or galactose. We find that the luciferase activity is modulated by the expression of Ipc1. Treatment with DAG activates luciferase in a dose- and time-dependent manner only when the luciferase gene is under the control of the APP1 promoter, whereas treatment with ceramide/phytoceramide or sphingosine/phytosphingosine does not affect APP1 transcription. We identified two consensus sequences in the APP1 promoter for AP-2 and ATF cis-acting elements. Deletion of the ATF consensus sequence in the APP1 promoter abolishes luciferase activity, whereas mutation of ATF abrogates the DAG-dependent activation. Deletion or mutation of AP-2 causes a significant increase of APP1 transcription, suggesting that this consensus sequence acts as a negative regulator. Finally, we identified and deleted the putative C. neoformans ATF2 gene by homologous recombination and found that loss of Atf2 abrogates luciferase activation driven by the APP1 promoter and regulated by Ipc1 or DAG. Thus, these studies suggest that APP1 transcription is under the control of the Ipc1-DAG pathway through the Atf2 transcription factor and two consensus sequences (AP-2 and ATF) present in the APP1 promoter. Strains, Growth Media, and Reagents—C. neoformans var. grubii serotype A strain H99 and derivative mutants used in this study are illustrated in TABLE ONE. The strains were routinely in yeast with glucose or was used to or the expression of at a of was to for of the and strains, as B at a of was to for of and C. neoformans strains TABLE were routinely of hygromycin of C. neoformans strains used in this C. Toffaletti D.L. A. Perfect J.R. Hannun Y.A. Del Poeta M. 2001; PubMed Scopus Google C. Toffaletti D.L. A. Perfect J.R. Hannun Y.A. Del Poeta M. 2001; PubMed Scopus Google study in a assay was to and K. Methods Enzymol. 1999; PubMed Scopus Google Scholar). C. neoformans and strains were in a for at were in sterile-distilled water and in glucose or for at were at in in of of and at for 1 The cell was at in of and for 1 of of enzyme was and cells were at for 1 Next, cells were at for at and with were and for in of of at for 1 at the cells were in of 1 of and 1 of The was at for and by the of 1 of 1 and of I. The was for at and an of and was and the at for The mRNA was using and with The mRNA was in of water and to the in which and APP1 were using a the the were for at in the mRNA was the were at for the were at for in and at for in and and at for in and were and to at for was by a of C. neoformans the under the of or of the APP1 was as the gene under the control of the C. neoformans actin promoter was the by using and which and The was The gene was using and and as a The was with and and the and The was with and a that was and The was with and to the and region of the APP1 gene the C. Hannun Y.A. Lipids. 1999; 34: S5-S11Crossref PubMed Google Scholar), Next, a to the APP1 promoter was by that with and and and which was C. neoformans and GAL7:IPC1 to and This APP1 sequence was it was highly to be the promoter of 1) it the sequence of the APP1 mRNA region it contains the and two putative consensus sequences for transcription AP-2 and ATF and it was highly to be a promoter region when the at the of was as a to the untranslated region of the APP1 promoter was using and which and and The was the This was with and and the was the and The was the GAL7:IPC1 strain to the negative control was as of the APP1 was using and which and and C. neoformans actin promoter was using and which and and These were with the enzymes and the and The was the C. neoformans H99 strain to the control was as C. Hannun Y.A. Lipids. 1999; 34: S5-S11Crossref PubMed Google Scholar) was with and a to the of the APP1 promoter. The was and and The was the C. neoformans H99 strain to the The were the to of the were for analysis and was and to analysis with to a at the APP1 not was as the was the using and which and The was in which was with The was the and by the were by in the The ATF consensus sequence was deleted in the using and and the was The AP-2 consensus sequence was deleted in the using and and the was the The ATF consensus sequence was also deleted in the in the the ATF consensus sequence was by using and and the as a The was the The AP-2 consensus sequence was by using and and as a The was the The were to to that the and These were the strain to Toffaletti D.L. S.A. Perfect J.R. J. Bacteriol. PubMed Google Scholar). The were hygromycin and that not the were the for to and Perfect A. Perfect J.R. Cryptococcus neoformans. D. Scholar). analysis of was to not the and were and C. neoformans and strains, Ipc1 and activity was as C. Toffaletti D.L. A. Perfect J.R. Hannun Y.A. Del Poeta M. 2001; PubMed Scopus Google Scholar). activity was to the in the were to Luberto C. Toffaletti D.L. A. Perfect J.R. Hannun Y.A. Del Poeta M. 2001; PubMed Scopus Google Scholar). of cell was to of luciferase assay and the of luciferase was by a were 1 of C. neoformans strains were the in a for at were with in and in the in a for at Next, cell were with in and Next, were in of and 1,2-dioctanoylglycerol for and at in a were and luciferase activity was of C. neoformans ATF2 and the transcription for APP1 we the AP-2 gene AP-2 and and ATF gene ATF2 and the C. neoformans H99 The identified sequence with an of to for the Atf2 or transcription whereas we not find significant with other ATF or AP-2 transcription factors. Thus, we of the sequence identified in which was putative C. neoformans The sequence was and the sequence was with ATF2 and A putative the region and the of the domain was Thus, the to the region of the ATF2 gene was using and which and and and C. neoformans H99 as a Next, the to the region of the ATF2 gene was using and which and and and the C. neoformans H99 as a Finally, the was the using and which and and The and were with and and the which was the C. neoformans H99 strain and GAL7:IPC1 strain and analysis was using Ipc1 of previous studies, we found that APP1 mRNA are regulated by Ipc1 modulation (16Luberto C. Martinez-Marino B. Taraskiewicz D. Bolanos B. Chitano P. Toffaletti D.L. Cox G.M. Perfect J.R. Hannun Y.A. Balish E. Del Poeta M. J. Clin. Investig. 2003; 112: 1080-1094Crossref PubMed Scopus (115) Google Scholar). Thus, we investigated whether Ipc1 regulates APP1 gene expression at the transcriptional A assay was used to the level of APP1 mRNA Ipc1 that when Ipc1 is strain in the transcription of and APP1 mRNA with the These suggest that of Ipc1 APP1 transcription. The assay was also in in which Ipc1 was We found using this APP1 mRNA in the GAL7:IPC1 strain glucose with the strain not suggesting that the of the is not To the APP1 transcription is regulated by Ipc1, a of the of the APP1 gene was fused to the luciferase reporter gene of the firefly in both and GAL7:IPC1 strains, and The and strains were in glucose and and luciferase activity was of Ipc1 a significant increase of luciferase activity in the strain, previous with the in which of Ipc1 APP1 transcription. was significant in the luciferase activity glucose and of the strain, suggesting that the does not affect APP1 transcription (Fig. under in which Ipc1 is luciferase activity does not the wild-type These suggest that when Ipc1 is may to an increase of DAG level by other than that regulated by Ipc1. This is by that a of DAG under of Ipc1 is and in the of growth (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar). is also that of the of the promoter, the of be using these at a On the other hand, in previous studies we showed that APP1 mRNA by are when Ipc1 is (16Luberto C. Martinez-Marino B. Taraskiewicz D. Bolanos B. Chitano P. Toffaletti D.L. Cox G.M. Perfect J.R. Hannun Y.A. Balish E. Del Poeta M. J. Clin. Investig. 2003; 112: 1080-1094Crossref PubMed Scopus (115) Google Scholar). Thus, it is that under in which Ipc1 is the APP1 mRNA level as a of an of APP1 this regulatory mechanism Thus, to whether APP1 transcription can be and by Ipc1, the strain was to and these both Ipc1 and luciferase were in B and of Ipc1 luciferase activity, whereas of the cells to an increase of luciferase These suggest that modulation of Ipc1 regulates APP1 transcription. a we fused the actin promoter to the luciferase gene the C. neoformans H99 wild-type strain, a a negative we used a sequence of the APP1 promoter and fused it to the luciferase gene in the GAL7:IPC1 strain, a strain and for were in glucose or and luciferase activity was the strain not luciferase activity, under in which Ipc1 was or (Fig. The strain showed a level of luciferase activity that was not modulated by the (Fig. luciferase activity was at a level, as in these suggest that the sequence to the APP1 promoter activates activity and that APP1 transcription is under the control of Ipc1. DAG APP1 in previous studies we showed that C. neoformans Ipc1 regulates the level of phytoceramide and DAG (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar), we whether treatment with DAG or phytoceramide would affect luciferase Thus, the and strains were with of DAG, and luciferase activity was We found a dose- and time-dependent increase of luciferase activity in the strain with DAG (Fig. A and treatment with DAG not increase luciferase activity in the strain (Fig. and not activate luciferase in the strain (Fig. Ipc1 also regulates the level of phytoceramide (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar), we whether luciferase activity would be modulated by treatment with ceramides or We found luciferase activity when cells were to of or phytosphingosine not These suggest that DAG may be the of the Ipc1 regulation the APP1 promoter. APP1 by ATF and AP-2 of regulation of the APP1 promoter, a for consensus sequences for transcription was The revealed the presence of two putative consensus sequences by transcription AP-2 and at and In mammalian cells, it has been that DAG may a regulatory the transcription N. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus (115) Google Scholar, M. R.L. J. Biochem. 1996; PubMed Scopus Google Scholar, K. G. A. Biochem. Biophys. PubMed Scopus Google Scholar). it has been that AP-2 transcriptional activation in to DAG and the pathway or in to the pathway M. R. M. Full Text PDF PubMed Scopus Google Scholar). to previous in which Ipc1 activates C. neoformans Pkc1 through DAG in (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar) and in (15Heung L.J. Kaiser A.E. Luberto C. Del Poeta M. J. Biol. Chem. 2005; 280: 28547-28555Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar), it was to that Ipc1-DAG would regulate APP1 transcription through ATF or/and To this we a of of the APP1 promoter the two cis-acting (AP-2 and The was fused to the gene and it was the APP1 in the strain the strain (Fig. or in the strain using the (Fig. the that the is to activate luciferase activity in both strains in which the is or (Fig. and luciferase activity by the is not that by the APP1 promoter (Fig. of Ipc1 luciferase activity when the gene is driven by the (Fig. to was in the strain (Fig. Next, the and strains were with DAG, and luciferase activity was in B and DAG luciferase activity in a These suggest that the is to luciferase activation by Ipc1 and DAG in strains in which the is or activity of and strains in glucose and and DAG strain in glucose or showed luciferase in The strain in showed a significant increase of luciferase activity with glucose in of luciferase activity in the strain in activity in a strain with of luciferase activity in the strain in The treatment a significant of luciferase activity in a of were at Next, we the of the or of AP-2 and ATF consensus sequences luciferase Thus, AP-2 or ATF or or were in the strain (Fig. as were by analysis of and only the were not In the strains, the AP-2 or ATF consensus sequence were the APP1 promoter, whereas in the strains two in the ATF or AP-2 consensus sequence were and for in the of ATF luciferase activity, whereas of AP-2 luciferase activity by (Fig. the ATF consensus sequence was the luciferase activity was not (Fig. DAG activation was (Fig. Treatment with DAG not increase luciferase activity in the or strains (Fig. suggesting that DAG a negative AP-2 These suggest that the two in the ATF consensus sequence are for the activation of APP1 transcription. This is by studies in mammalian cells, in which mutation of these two in the ATF cis-acting abrogates the activation of the promoter by J. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). Thus, other that the ATF cis-acting as a M. R.L. J. Biochem. 1996; PubMed Scopus Google Scholar, K. G. A. Biochem. Biophys. PubMed Scopus Google Scholar, J. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). activation by DAG was also when the AP-2 consensus sequence was deleted or it would suggest that DAG also an Thus, we that ATF is involved in the expression of APP1 and that DAG controls APP1 expression through ATF and through is that luciferase activity is AP-2 or the of DAG activate luciferase or that DAG inhibits AP-2 activity that is when AP-2 is deleted or are required to whether DAG and Ipc1 modulation would affect the of transcription to ATF or/and AP-2 cis-acting of the C. neoformans APP1 promoter. of ATF2 in APP1 the putative C. neoformans ATF2 gene was identified and for the putative C. neoformans ATF2 gene was deleted in both and strains, and (Fig. A and were in glucose or or with DAG, and luciferase activity was We found that both strains a of luciferase activity, which is under the control of Ipc1 modulation (Fig. C and or DAG treatment (Fig. and these suggest that the C. neoformans Atf2 transcription factor may be by the Ipc1-DAG pathway to increase the transcription of APP1 through ATF AP-2 cis-acting of the APP1 promoter. The molecular Atf2 and the APP1 promoter has yet to be elucidated. is to that an AP-2 homolog was not found in the C. neoformans the Atf2 transcription factor may to both ATF and AP-2 cis-acting and that the presence of DAG Atf2 may the of the to AP-2 the to a APP1 transcription On the other hand, it is that DAG regulates a transcription factor yet to be identified that to the putative AP-2 consensus The in this this The the mechanism by which Ipc1-DAG activates the transcription involved in the regulation of APP1 transcription is also In mammalian cells, Atf2 known as can be by J. R. R. K. Y. N. 12: PubMed Scopus Google Scholar), ATF transcription are by the pathway in 2003; PubMed Scopus Google Scholar). On the other hand, in the yeast the transcription factor is homologous to the mammalian Atf2 and is regulated by protein kinase pathway but not by the pathway M. T. T. N. 1996; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, T. T. K. A. M. N. J. 1995; PubMed Scopus Google Scholar). the S. protein was the C. neoformans H99 the sequence identified by the Atf2 was found with an of This that the putative C. neoformans ATF2 gene that we identified is to the Atf2 and S. transcription factors. the role and mechanisms by which ATF transcription is regulated in pathogenic fungi, such as C. albicans, C. neoformans, and A. are these studies, we that C. neoformans Atf2 is under the control of the Ipc1-DAG pathway. This control may be exerted by Pkc1 C. neoformans Pkc1 is also regulated by the Ipc1-DAG pathway (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar, L.J. Kaiser A.E. Luberto C. Del Poeta M. J. Biol. Chem. 2005; 280: 28547-28555Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). studies showed that treatment with in to the mammalian also inhibits C. neoformans Pkc1 (14Heung L.J. Luberto C. Plowden A. Hannun Y.A. Del Poeta M. J. Biol. Chem. 2004; 279: 21144-21153Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar), abolishes the activation of luciferase by DAG in the strain, Del the that DAG may activate Atf2 through Pkc1. that Ipc1 controls Pkc1 in C. neoformans (15Heung L.J. Kaiser A.E. Luberto C. Del Poeta M. J. Biol. Chem. 2005; 280: 28547-28555Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar) and in mammalian cells, Atf2 is required for activation L. G. Biol. Chem. 2003; PubMed Scopus Google Scholar, M. Biochem. PubMed Scopus Google Scholar), the that may activate APP1 transcription through the Atf2 transcription factor and ATF AP-2 cis-acting is is that the study of regulation of gene that C. neoformans to the and is a of the recent of the sequence of this E. P. D. P. D. J. M. J.A. R. J. M. G. R. M.A. M. A. M. A. J.R. J. 2005; PubMed Scopus Google Scholar) and the of C. neoformans this we the of luciferase as a reporter for gene expression as an for gene transcription of C. neoformans in using this we the pathway and we that the mechanism by which Ipc1 regulates APP1 transcription is through the of DAG and the activation of Atf2 (Fig. The presence of and putative in the regulation of APP1 transcription would suggest that the gene may be only under of the In previous studies, App1 protein was found in of by of C. neoformans regulate the of App1 protein to by cells and it yeast cells would be This regulation would the to would to and their with the In both an and C. neoformans may such as the of App1 protein other antiphagocytic such as the which can be and the to the the of the these are regulated and they fungal the is a of We and in for with the luciferase We also and Obeid for Taraskiewicz for and for We to Perfect for the of the and
26
The Genome of the Basidiomycetous Yeast and Human Pathogen <i>Cryptococcus neoformans</i>
Brendan Loftus, Eula Fung, Paola Roncaglia et al. · Science · 2005 · 726 citations
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA
Dena L. Toffaletti, Thomas H. Rude, S. A. Johnston et al. · Journal of Bacteriology · 1993 · 507 citations · Full text